United States

Substandard and falsified (SF) pharmaceuticals account for an estimated 10% of the pharmaceutical supply chain in low- and middle-income countries (LMICs), where a lack of regulatory and laboratory resources limits the ability to conduct effective post-market surveillance and allows SF products to penetrate the supply chain. The Distributed Pharmaceutical Analysis Laboratory (DPAL) was established in 2014 to expand testing of pharmaceutical dosage forms sourced from LMICs; DPAL is an alliance of academic institutions throughout the United States and abroad that provides high quality, validated chemical analysis of pharmaceutical dosage forms sourced from partners in LMICs. Results from analysis are reported to relevant regulatory agencies and are used to inform purchasing decisions made by in-country stakeholders. As the DPAL program has expanded to testing more than 1000 pharmaceutical dosage forms annually, challenges have surfaced regarding data management and sample tracking. Here, we describe a pilot project between DPAL and ARTiFACTs that applies blockchain to organize and manage key data generated during the DPAL workflow, including a sample’s progress through the workflow, its physical location, provenance of metadata, and lab reputability. Recording time and date stamps with this data will create a permanent and verifiable chain-of-custody for samples. This secure, distributed ledger will be linked to an easy-to-use dashboard, allowing stakeholders to view results and experimental details for each sample in real time and verify the integrity of DPAL analysis data. Introducing this blockchain-based system as a pilot will allow us to test the technology with real users analyzing real samples. Feedback from users will be recorded and necessary adjustments will be made to the system before the implementation of blockchain across all DPAL sites. Anticipated benefits of implementing blockchain for managing DPAL data include efficient management for routing work, increasing throughput, creating a chain of custody for samples and their data in alignment with the distributed nature of DPAL, and using the analysis results to detect patterns of quality within and across brands of products and develop enhanced sampling techniques and best practices.

ConV2X

Securing the chain of custody and integrity of data in a global north-south partnership to monitor the quality of essential medicines

Watch the acclaimed health tech modernization symposium sessions catalyzing C-suite global market executives driving healthcare to the next plateau through initiatives, policy, trust building and low cost health solutions at **#ConV2X 2021 “Driving Telehealth & Technology: Blueprint for a New Digital Health Era”**

Focusing on health policy, telehealth and virtual care, blockchain and edge technologies, **ConV2X 2021** is the premier destination community identifying new and cost effective paths forward through real world evidence, strategy, operations, research & trends.

Enjoy the talks of healthcare leadership & breakthrough technology providers that inspire and guide informed decision making for health policy development, health systems and world citizens to successfully navigate a new digital health era.

Focusing on health policy, telehealth and virtual care, blockchain and edge technologies, ConV2X 2021 is the premier destination community identifying new and cost effective paths forward through real world evidence, strategy, operations, research & trends.

technical paper

Panel experts will discuss understanding what accessible “patient-centered” mRPM entails from both a clinical and technology perspective, outline current challenges impacting innovation and trust in the use of mRPM from regulatory, physician and patient perspectives and detail benefits and gaps in making mRPM accessible for all patients.

The Future of Patient-Centered mRPM

Learn the latest developments, solutions and forward-looking approaches with this technology for healthcare. How do panelists view healthcare delivery systems changing through blockchain-powered technology? What solutions are they spearheading along with new models of collaborations with which they are involved? The panel will highlight how blockchain is leveraged to transform health systems.

Shaping the Future of Healthcare Through Blockchain-Powered Technology

A candid discussion that dives into the recesses of AI and ethics including topics such as what lessons can be used in healthcare from tech players implementing responsible AI and unbiased systems, how can responsible AI help build a clinical support system, examples from providers and payers and learnings from responsible AI which can be used in Obamacare and clinical trial implementation.

Responsible AI in Healthcare: Best Practices to Improve Healthcare Delivery

Brian M. Thornley leads the global supply strategy from plant to patient. He oversees Merck’s digital supply chain strategy including blockchain enabled pharma, organization development and enterprise segmentation to optimize service, cost, earnings and return on capital employed. Previously, he was AVP Supply Chain Operations EMEA & AP, including Planning and Strategy for Merck MSD, developing the strategic approach to deliver internal efficiencies and external transformation of the supply chain from factories to end customer. Before joining MSD he was the COO of Aegate Ltd, implementing integrated data and information networks directly with pharmacies across Europe and the first commercial pharmaceutical authentication system across the European pharmacy network. Brian provided consultancy support to the PGEU, the representative body of pharmacies in Europe.

Blockchain is a Team Sport

How is blockchain technology empowering patients and authorities through Asia’s first blockchain solution for supply chain connectivity and traceability for pharmaceuticals and vaccines. With 2 MILLION products on the blockchain network, this scalable initiative controls “pack” vs “batch,” where consumers verify their drug(s) and vaccines are effective, safe and efficacious, while authorities are arresting counterfeit bad actors!

Life Science Business Value of Blockchain Case Use

Topics such as supply chain, clinical trials and health data will be explored along with how blockchian can exist in harmony with GDPR.

PharmaLedger: Blockchain-Enabled Healthcare: Privacy-Enhancement with Blockchain

Don’t miss this opportunity to glean valuable market intel from leading experts including M&As, NewCos, SPACS, speculative bubbles, evaluating the consumer and provider experience, Big Tech failures and successes and future predictions. Why are public telehealth companies doing poorly and why are “niche” telehealth companies getting so much investor money? What are the major hurdles for the widespread adoption of virtual primary care tools? What are your views on the new entrants in the marketplace such as Amazon Care?

Health Tech Analyst Commentary & Market Watch

The keynote highlights how rising healthcare costs, drivers of waste in the system, and an outdated infrastructure slow innovation and create a poor patient experience. A modern infrastructure that connects the healthcare ecosystem is needed to deliver data liquidity with security. Modernizing the infrastructure of healthcare empowers innovation in blockchain, AI, DLT, and NLP.

Accelerating Healthcare with Innovation in Blockchain

Learn and prepare for breaches with a pre-emptive stance and not just when there is an imminent threat.

Quantum Techniques and Technologies for Cybersecurity in Healthcare

This session will unlock swarm principals, challenges and opportunities in clinical R&D. Topics will include understanding the differences between federated machine vs swarm learning, technical, policy and application barriers relating to transferring significant amounts of data, frameworks needed to drive wider understanding and adoption.

Premium content

Downloads

Next from ConV2X

The Future of Patient-Centered mRPM

Similar lecture

The State of Data Onboarding, Interoperability and Trust